Eugene, OR-K. Dunn & Associates has released a set of marketing tools for ophthalmologists to promote the use of botulinum toxin type A (Botox, Allergan) in their local markets.
Study: “Brain bleeds” in babies’ first year can lead to long-term sight problems
First patient enrolled in Phase 2 study evaluating therapeutic for persistent corneal epithelial defects
Novel therapy using thermogel prevents retinal scarring